Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-6424.54%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -55.77M | -6424.54% | $ 868K |
| 3/31/2025 | $ -66.36M | -3583.37% | $ 1.85M |
| 12/31/2024 | $ -72.03M | -3178.6% | $ 2.27M |
| 9/30/2024 | $ -84.08M | -3694.24% | $ 2.28M |
| 6/30/2024 | $ -105.33M | -4383.15% | $ 2.4M |
| 3/31/2024 | $ -120.36M | -6854.16% | $ 1.76M |
| 12/31/2023 | $ -155.01M | -11232.32% | $ 1.38M |
| 9/30/2023 | $ -166.78M | -13428.5% | $ 1.24M |
| 6/30/2023 | $ -160.38M | -15451.25% | $ 1.04M |
| 3/31/2023 | $ -155.28M | -26726.51% | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average OCF % has been -18015.16%.
- The median OCF % for BIOXCEL THERAPEUTICS INC during this period was -9043.24%
- BIOXCEL THERAPEUTICS INC reached its highest OCF % over the past 5 years at -3178.6%.
- The lowest OCF % recorded by BIOXCEL THERAPEUTICS INC in the same timeframe -85134.31%
BIOXCEL THERAPEUTICS INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for BIOXCEL THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -54M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ] BTAI - Operating Cash Flow Margin, Last 5 years
-85134.31%
Minimum
Sep 30, 2022
-3178.6%
Maximum
Dec 31, 2024
-18015.16%
Average
-9043.24%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 78.12% |
| average | 14.35% |
| median | 12.67% |
| std | 21.14% |